Granzyme B is a prognostic marker of PFS in FL. The graph shows progression-free survival (PFS) in the 80 patients scored by IHC after R-combined chemotherapy. According to the GrzB scoring system, as described in “IHC,” association was found between a poor outcome of treatment and a low GrzB score.